[Evaluation of urine NMP22 point-of-care test for the screening of bladder cancer].

@article{Ihm2007EvaluationOU,
  title={[Evaluation of urine NMP22 point-of-care test for the screening of bladder cancer].},
  author={Chun hwa Ihm and Jimyung Kim and Yong Hak Sohn},
  journal={The Korean journal of laboratory medicine},
  year={2007},
  volume={27 2},
  pages={106-10}
}
BACKGROUND Screening of high-risk patients using bladder tumor markers can offer an advantage of early detection and saving medical costs. For these purpose many tumor markers have been developed to supplement invasive cystoscopy. Our study evaluated the NMP22 point-of-care test (NMP22 POCT), which is one of the tumor makers, comparing with the standard… CONTINUE READING